Sara E. Cosgrove - Concepedia

Author

Sara E. Cosgrove

Also Known As

Alicia Arbaje, Bradford Winters, Cecilia Johnston, Cosgrove, Sara E., Eric Hadhazy, Fidelia Bernice, Helen Boucher, Lisa Maragakis, Ritu Banarjee, Ritu Banerjee

463

Publications

38.9K

Citations

H-Index

140

Concepts

All Affiliations

Johns Hopkins University Johns Hopkins Medicine Johns Hopkins Hospital University of Maryland, Baltimore National Patient Safety Foundation

About

Sara E. Cosgrove is an author at Johns Hopkins University specializing in medicine, infection control, and antibiotics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	32	55	12.6K
2	Health Sciences	12	12	7K
3	Humanities	3	3	71
4	Nursing	3	3	50
5	Engineering	2	2	44

Sara E. Cosgrove

186

Publications

33.4K

Citations

H-Index

Page 1

	Year	Citations
An Intervention to Decrease Catheter-Related Bloodstream Infections in the ICU Peter J. Pronovost, Dale M. Needham, Sean M. Berenholtz, New England Journal of Medicine	2006	4.3K
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children Catherine Liu, Arnold S. Bayer, Sara E. Cosgrove, Clinical Infectious Diseases Antibiotic AdjuvantMrsa StrainsDermatologyInfectious Diseases SocietyClinical Practice Guidelines	2011	4.1K
Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Tamar F. Barlam, Sara E. Cosgrove, Lilian M. Abbo, Clinical Infectious Diseases	2016	2.8K
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children: Executive Summary Catherine Liu, Arnold S. Bayer, Sara E. Cosgrove, Clinical Infectious Diseases Antibiotic AdjuvantMrsa StrainsDermatologyInfectious Diseases SocietyClinical Practice Guidelines	2011	1.6K
Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by <i>Staphylococcus aureus</i> Vance G. Fowler, Helen W. Boucher, G. Ralph Corey, New England Journal of Medicine	2006	1.5K
The Relationship between Antimicrobial Resistance and Patient Outcomes: Mortality, Length of Hospital Stay, and Health Care Costs Sara E. Cosgrove Clinical Infectious Diseases Staphylococcus AureusAntibiotic ResistanceDrug ResistanceHealthcare-associated InfectionAntimicrobial Therapy	2005	1.3K
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial Paul M. Ridker, Jean MacFadyen, Tom Thurén, The Lancet InflammationAllergyLung InflammationMedicineMetronomic Therapy	2017	1.3K
Adverse Clinical and Economic Outcomes Attributable to Methicillin Resistance among Patients with<i>Staphylococcus aureus</i>Surgical Site Infection John J. Engemann, Yehuda Carmeli, Sara E. Cosgrove, Clinical Infectious Diseases Economic Outcomes AttributableAdverse ClinicalAntibiotic ResistanceLogistic AnalysisHospital Medicine	2003	933
The Impact of Methicillin Resistance in <i>Staphylococcus aureus</i> Bacteremia on Patient Outcomes: Mortality, Length of Stay, and Hospital Charges Sara E. Cosgrove, Youlin Qi, Keith S. Kaye, Infection Control and Hospital Epidemiology	2005	858
Association of Adverse Events With Antibiotic Use in Hospitalized Patients Pranita D. Tamma, Edina Avdic, David X. Li, JAMA Internal Medicine	2017	723

Page 1